US Patent

US11154498 — Stabilized liquid formulation of levothyroxine

Formulation · Assigned to Leiutis Pharmaceutials LLP · Expires 2036-07-20 · 10y remaining

Vulnerability score 42/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a stabilized liquid formulation of levothyroxine for parenteral administration.

USPTO Abstract

The present invention relates to stabilized liquid formulations of Levothyroxine or a pharmaceutically acceptable salt thereof, intended for parenteral administration. Further this invention also describes process of preparing such compositions.

Drugs covered by this patent

Patent Metadata

Patent number
US11154498
Jurisdiction
US
Classification
Formulation
Expires
2036-07-20
Drug substance claim
No
Drug product claim
Yes
Assignee
Leiutis Pharmaceutials LLP
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.